IP Group

IP Group, established in 2001 and headquartered in London, specializes in commercializing intellectual property from research-intensive institutions. The company's core business involves identifying promising IP, managing its development, and creating value through either building businesses or forging strategic partnerships. IP Group's success stems from its deep expertise in IP management, combined with insights into both industry and finance, consistently delivering strong results for its companies, partners, and shareholders.

Dani Bach

Partner, Life Sciences

Jon Edington

Partner, Technology

Michael Molinari

Managing Director, IP Group Australia

Ben Murphey

Investment Director

Mark Reilly

Managing Partner, Technology

Greg Smith

CEO and Board Member

Lee Thornton

Partner, Technology

Jamie Vollbracht

Partner, Cleantech

Ben Murphy

Investment Director, Kiko Ventures

Past deals in United Kingdom

Diffblue

Series A in 2024
Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Alesi Surgical

Venture Round in 2024
Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

Enterprise Therapeutics

Series B in 2024
Enterprise Therapeutics, established in 2014 and headquartered in Brighton, UK, is a drug discovery company focused on developing therapies for respiratory diseases. Its primary focus is on chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company aims to create novel treatments that target the underlying mechanisms of mucus congestion, reducing lung infections and enhancing patients' quality of life.

AccelerComm

Series B in 2023
AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

Deep Render

Series A in 2023
Deep Render Ltd. is a London-based AI start-up that originated from the Department of Computing at Imperial College London. The company specializes in developing advanced media compression algorithms using proprietary and patented technology grounded in machine learning research. Its innovative approach focuses on deep learning, density estimation, and unsupervised learning, resulting in state-of-the-art Biological Image Compression that offers at least a 50% efficiency gain over existing standards. Deep Render's technology is notable for being the first AI-based codec capable of real-time video playback, allowing for significant market expansion and cost reduction for users.

AudioScenic

Series A in 2023
AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing advanced 3D audio technology that enhances the listening experience across various sectors, including cinema, gaming, production, automotive, and public spaces. The company's innovative approach utilizes small arrays of speakers combined with head-tracking technology to deliver controlled sound beams directly to the listener's ears, creating a virtual headphone effect without the need for traditional headphones or bulky speaker setups. This technology allows users to experience immersive audio that accurately simulates sound positioned in three-dimensional space, surpassing the quality of conventional loudspeaker systems. AudioScenic's solutions are adaptable for diverse applications and are supported by their proprietary Virtua 3D Engine, which is designed for efficient signal processing across various platforms. The company collaborates closely with partners and customers to provide tailored acoustic designs, ensuring an authentic and natural audio experience for all users.

Diffblue

Series A in 2022
Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Nexeon

Series D in 2022
Nexeon Limited is a developer and manufacturer of advanced silicon-based anode materials for rechargeable lithium-ion batteries. Founded in 2006 and headquartered in Abingdon, United Kingdom, with an additional office in Yokohama, Japan, the company focuses on creating innovative battery materials that enhance energy density and capacity. These improvements allow for the production of lighter, more powerful batteries that can support a variety of applications, including consumer electronics, electric vehicles, sustainable energy, aerospace, medical, and defense industries. By enabling longer battery life and faster charging times, Nexeon's technology plays a crucial role in advancing sustainable energy solutions and supporting the transition to a net-zero environment. The company boasts a skilled technical team with diverse expertise to drive its research and development efforts.

Oxford Science Enterprises

Venture Round in 2022
Oxford Science Enterprises is a venture firm based in Oxford, United Kingdom, established in 2015 in partnership with the University of Oxford. The firm focuses on building and investing in companies that develop fundamental technologies aimed at addressing significant global challenges. Its investment areas include life sciences, healthcare, artificial intelligence, software, and deep tech, targeting issues such as nuclear fusion, quantum computing, and the development of treatments for infectious diseases. By leveraging its extensive experience and a robust network of investors, entrepreneurs, and sector experts, Oxford Science Enterprises aims to foster a world-class technology ecosystem and support the growth of innovative science-based businesses.

MoA Technology

Series B in 2022
MoA Technology Ltd. is a plant genetics company based in Leeds, United Kingdom, that was incorporated in 2017. It was spun out from the University of Oxford and focuses on developing innovative agricultural technologies aimed at enabling farmers to produce healthy food through sustainable crop systems. The company leverages research led by Professor Liam Dolan to discover new methods that enhance agricultural productivity while promoting sustainability.

SLAMcore

Series A in 2022
SLAMcore Limited specializes in developing simultaneous localization and mapping (SLAM) solutions tailored for various applications, including robotics, augmented reality, and autonomous vehicles. Founded in 2016 and based in London, the company has created advanced SLAM software that enables robots and devices equipped with outward-facing sensors to understand and navigate unfamiliar environments. Their technology includes Visual SLAM, sensor fusion, and Event Camera SLAM, which collectively enhance real-time spatial understanding. By fusing data from multiple sensors, SLAMcore's platform utilizes computer vision and machine learning to improve the efficiency and accuracy of robotic systems. The company offers a software development kit (SDK) that facilitates rapid prototyping for commercial products, allowing for customization on standard computing platforms. Through partnerships with original equipment manufacturers, SLAMcore aims to integrate its core technology into everyday products, making spatial intelligence more accessible and practical in various industries.

GripAble

Series A in 2022
GripAble Ltd. designs and develops digital therapy devices aimed at improving rehabilitation for individuals with movement impairments such as stroke, arthritis, cerebral palsy, and trauma. Founded in 2017 and based in London, the company offers a portable, wireless handgrip device that connects to a mobile application. This application allows users to engage with therapy games while providing assessment and training for hand and arm functions. GripAble's innovative approach focuses on making therapy more accessible and engaging for patients, enabling them to practice essential daily tasks in a fun and motivating way. By combining hardware and software, GripAble addresses the needs of over 500 million people worldwide who face challenges with arm mobility, facilitating self-training both in clinical settings and at home.

First Light Fusion

Series C in 2022
First Light Fusion Limited, founded in 2011 and based in Begbroke, United Kingdom, specializes in advanced implosion processes for electricity generation through inertial confinement fusion. The company originated as a spin-out from the University of Oxford and actively engages in researching and developing sustainable renewable energy solutions. It employs a team of engineers and physicists and collaborates with several academic institutions, including the University of Oxford, Warwick University, UCL, and Imperial College London. First Light Fusion focuses on harnessing fundamental physics to discover new energy sources, utilizing detailed numerical simulations and experimental validation in its research efforts.

Bramble Energy

Series B in 2022
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

Diffblue

Seed Round in 2022
Diffblue Limited, based in Oxford, United Kingdom, specializes in artificial intelligence software that automates various coding tasks, primarily focusing on enhancing Java development through automated testing solutions. Founded in 2016 as a spin-out from the AI research group at Oxford, Diffblue's technology autonomously generates unit tests, which helps developers save time and ensure software robustness. The software not only creates fully formed tests guaranteed to compile and run, but also identifies and fixes bugs, refactors code, and maintains regression tests. By providing insights into test coverage, code testability, and complexity, Diffblue aims to transform the software development process, making it more efficient and less error-prone.

Navenio

Venture Round in 2021
Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.

Ieso

Series B in 2021
Ieso Digital Health Ltd. is a provider of online, evidence-based mental health therapy, focusing on cognitive behavioral therapy (CBT) delivered through a digital platform. The company offers one-to-one therapy sessions for various mental health issues, including anxiety, depression, and phobias, as well as support for chronic physical health problems and cognitive impairments. Ieso's innovative approach combines proprietary technology with natural language processing and artificial intelligence to enhance therapy delivery through real-time monitoring and assessment. This enables therapists to provide effective care in a virtual environment, allowing patients to access support at their convenience. Serving a diverse clientele that includes health providers, private individuals, and businesses, Ieso aims to transform mental healthcare by making it more accessible and scalable. Founded in 2000 and based in Swavesey, United Kingdom, Ieso was previously known as PsychologyOnline.co.uk Limited before rebranding in 2015.

Ieso

Series B in 2021
Ieso Digital Health Ltd. is a provider of online, evidence-based mental health therapy, focusing on cognitive behavioral therapy (CBT) delivered through a digital platform. The company offers one-to-one therapy sessions for various mental health issues, including anxiety, depression, and phobias, as well as support for chronic physical health problems and cognitive impairments. Ieso's innovative approach combines proprietary technology with natural language processing and artificial intelligence to enhance therapy delivery through real-time monitoring and assessment. This enables therapists to provide effective care in a virtual environment, allowing patients to access support at their convenience. Serving a diverse clientele that includes health providers, private individuals, and businesses, Ieso aims to transform mental healthcare by making it more accessible and scalable. Founded in 2000 and based in Swavesey, United Kingdom, Ieso was previously known as PsychologyOnline.co.uk Limited before rebranding in 2015.

Ultraleap

Series D in 2021
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Monolith AI

Series A in 2021
Monolith AI Limited is a London-based software company that assists engineers in enhancing the product development process through the application of machine learning and data science. Founded in 2016, Monolith AI specializes in algorithms that integrate engineering simulations with machine learning techniques to identify optimal solutions for engineering designs. The company enables organizations to leverage existing simulation and test data, allowing them to predict the behavior of new products. This approach helps businesses streamline their research and development processes by minimizing the need for extensive simulations, tests, and prototypes, ultimately leading to faster and more effective product development. Monolith AI was formerly known as UQuant Limited and rebranded in June 2018.

Alesi Surgical

Venture Round in 2021
Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

Oxford Nanopore Technologies

Venture Round in 2021
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Oxular

Venture Round in 2021
Oxular Limited is a clinical-stage company based in Oxford, United Kingdom, focused on developing innovative retinal treatments to address various retinal diseases. Founded in 2014, the company specializes in tissue-specific drug delivery technology aimed at improving the effectiveness of treatments for conditions such as age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and cystoid macular edema. By targeting specific areas within the eye, Oxular seeks to enhance therapeutic outcomes while minimizing side effects and reducing the frequency of treatments, thereby offering patients effective and life-changing solutions for their unmet medical needs.

C-capture

Venture Round in 2021
C-Capture Limited, founded in 2008 and based in Leeds, United Kingdom, specializes in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The company utilizes its expertise in CO2-based chemistry and engineering to create absorbents for reversible CO2 capture, particularly in post-combustion processes. C-Capture focuses on providing non-toxic and economically viable carbon capture solutions for emission sources, including flue gases from power generators and hard-to-abate industries. By offering innovative technology for capturing CO2, C-Capture aims to contribute to more sustainable electricity generation and address the environmental challenges posed by greenhouse gas emissions.

Econic Technologies

Debt Financing in 2020
Econic Technologies Ltd. is a UK-based chemical technology company that specializes in developing innovative processes for producing polymers and polyurethanes using carbon dioxide and epoxides. Founded in 2011 and located in Macclesfield, the company focuses on transforming waste CO2 into valuable materials through advanced catalyst chemistry. Its product offerings include polycarbonates and polycarbonate polyols, which find applications in various sectors such as mattresses, home insulation, footwear, packaging, and construction. The company’s technology not only reduces dependence on fossil fuels but also aims to provide environmental benefits by mitigating greenhouse gas emissions. With a team of skilled scientists and engineers operating from a state-of-the-art facility at Alderley Park, Econic Technologies is committed to advancing sustainable practices in the plastics industry while fostering economic growth.

AudioScenic

Series A in 2020
AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing advanced 3D audio technology that enhances the listening experience across various sectors, including cinema, gaming, production, automotive, and public spaces. The company's innovative approach utilizes small arrays of speakers combined with head-tracking technology to deliver controlled sound beams directly to the listener's ears, creating a virtual headphone effect without the need for traditional headphones or bulky speaker setups. This technology allows users to experience immersive audio that accurately simulates sound positioned in three-dimensional space, surpassing the quality of conventional loudspeaker systems. AudioScenic's solutions are adaptable for diverse applications and are supported by their proprietary Virtua 3D Engine, which is designed for efficient signal processing across various platforms. The company collaborates closely with partners and customers to provide tailored acoustic designs, ensuring an authentic and natural audio experience for all users.

AccelerComm

Series A in 2020
AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

Bramble Energy

Series A in 2020
Bramble Energy Ltd. is a London-based company that specializes in the design, development, and manufacture of printed circuit board (PCB) fuel cells, specifically proton exchange membrane fuel cells (PEMFCs). Incorporated in 2015, it leverages the capabilities of the global PCB industry to produce high-performance, cost-effective fuel cell stacks. The company's product lineup includes modular PCBFC stacks, ranging from 20 W to 5 kW, as well as custom-designed solutions. Bramble Energy serves various sectors, including stationary, portable, and automotive applications, aiming to provide gigawatts of fuel cell hardware. By utilizing innovative manufacturing methods and materials, the company enables clients to reduce energy consumption and lower their carbon footprints.

IBEX Innovations

Venture Round in 2020
IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

Navenio

Series A in 2020
Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.

Mixergy

Series A in 2019
Mixergy Ltd, founded in 2014 and based in Cassington, United Kingdom, specializes in the development of energy storage equipment, particularly hot water tanks. The company aims to provide cost-effective solutions that enhance energy efficiency and support the integration of renewable energy sources. By optimizing the use of solar photovoltaic systems and heat pumps, Mixergy tanks contribute to grid balancing, promoting greater utilization of renewable power generation.

WaveOptics

Series C in 2019
WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, the company focuses on creating optical components that enhance the augmented reality experience. Their patented technology utilizes waveguide hologram physics and photonic crystals, allowing for lightweight, high field-of-view displays in full RGB color. By employing thin transparent substrates embedded with nanostructures, WaveOptics' devices manipulate light to generate images without the need for bulkier components traditionally used in AR systems. The company has established strategic partnerships with industry leaders such as Compal, Wistron, and Plessey to further its mission in the augmented reality market.

Azuri Technologies

Corporate Round in 2019
Azuri Technologies Ltd. specializes in the development, manufacturing, and installation of solar power products aimed at off-grid communities, primarily in Africa and the United Kingdom. Founded in 2012 and headquartered in Cambridge, the company provides a variety of solar solutions, including AzuriTV, a solar-powered television, and various solar home systems that offer lighting, mobile phone charging, and other essential services. Its PayGo system allows users to access solar energy through a pay-as-you-go model, making clean energy affordable and accessible without the need for government subsidies. Azuri Technologies has established distribution networks in countries such as Kenya, Uganda, South Sudan, Zambia, and South Africa, addressing the energy access challenges faced by 1.3 billion people globally. By leveraging mobile technology, Azuri transforms energy access into a viable business, offering families a cost-effective alternative to traditional kerosene use.

IBEX Innovations

Venture Round in 2019
IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

Aqdot

Series B in 2019
Aqdot Limited, founded in 2012 and based in Cambridge, United Kingdom, specializes in manufacturing smart microcapsules through innovative fabrication technology. Its unique approach combines emulsion technology and supramolecular chemistry to simplify the microencapsulation process using a one-step shrink-wrap method. This technology is energy- and raw material-efficient, contributing to reduced energy consumption and waste. Aqdot's microcapsules have versatile applications across various industries, including home care, beauty, pet care, food, and agrochemicals. The encapsulation technology enables the protection and controlled release of active ingredients, making it suitable for products like laundry detergents, fertilizers, and odor-capturing technologies. With a focus on customization, Aqdot serves a multi-billion-dollar market, addressing the growing demand for effective and sustainable encapsulation solutions.

Inivata

Series B in 2019
Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, established in 2014. The company specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment for oncologists and their patients. Inivata's innovative approach utilizes TAm-Seq technology to detect and analyze genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples, known as liquid biopsies. This method revolutionizes cancer detection and monitoring by providing a less invasive alternative to traditional biopsies. The company's focus is on enabling clinicians to make more informed treatment decisions by monitoring response to therapies and detecting potential relapses in cancer patients. Inivata has also formed a strategic collaboration with NeoGenomics, Inc.

AccelerComm

Seed Round in 2019
AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

C-capture

Venture Round in 2019
C-Capture Limited, founded in 2008 and based in Leeds, United Kingdom, specializes in the development and design of solvent systems for the removal of carbon dioxide (CO2) from gas streams. The company utilizes its expertise in CO2-based chemistry and engineering to create absorbents for reversible CO2 capture, particularly in post-combustion processes. C-Capture focuses on providing non-toxic and economically viable carbon capture solutions for emission sources, including flue gases from power generators and hard-to-abate industries. By offering innovative technology for capturing CO2, C-Capture aims to contribute to more sustainable electricity generation and address the environmental challenges posed by greenhouse gas emissions.

AudioScenic

Seed Round in 2019
AudioScenic Limited, founded in 2017 and headquartered in Southampton, United Kingdom, specializes in developing advanced 3D audio technology that enhances the listening experience across various sectors, including cinema, gaming, production, automotive, and public spaces. The company's innovative approach utilizes small arrays of speakers combined with head-tracking technology to deliver controlled sound beams directly to the listener's ears, creating a virtual headphone effect without the need for traditional headphones or bulky speaker setups. This technology allows users to experience immersive audio that accurately simulates sound positioned in three-dimensional space, surpassing the quality of conventional loudspeaker systems. AudioScenic's solutions are adaptable for diverse applications and are supported by their proprietary Virtua 3D Engine, which is designed for efficient signal processing across various platforms. The company collaborates closely with partners and customers to provide tailored acoustic designs, ensuring an authentic and natural audio experience for all users.

WaveOptics

Series C in 2018
WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and based in Abingdon-on-Thames, United Kingdom, the company focuses on creating optical components that enhance the augmented reality experience. Their patented technology utilizes waveguide hologram physics and photonic crystals, allowing for lightweight, high field-of-view displays in full RGB color. By employing thin transparent substrates embedded with nanostructures, WaveOptics' devices manipulate light to generate images without the need for bulkier components traditionally used in AR systems. The company has established strategic partnerships with industry leaders such as Compal, Wistron, and Plessey to further its mission in the augmented reality market.

Ultraleap

Series C in 2018
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

IBEX Innovations

Venture Round in 2018
IBEX Innovations Limited specializes in developing and commercializing advanced X-ray detector technology that provides high sensitivity materials information using standard X-ray systems. Founded in 2010 by Dr. Gary Gibson and based in Sedgefield, United Kingdom, the company has created the IBEX multi absorption plate (MAP) technology, which enhances traditional detectors by integrating materials information while maintaining key performance characteristics like speed and spatial resolution. IBEX's solutions are utilized across various sectors, including healthcare for bone mineral density assessment, electronics inspection, food safety, and security applications. The company collaborates with academic institutions, such as the Mathematics Department at Durham University, and maintains partnerships with healthcare organizations to validate its technology in medical imaging. Supported by venture capital and grants, IBEX Innovations continues to advance its technology to transform standard X-ray imaging into powerful diagnostic tools.

Yoyo Wallet

Series C in 2018
Yoyo Wallet, established in 2013 and headquartered in London, specializes in mobile payment solutions. It offers a user-friendly app enabling customers to make in-store purchases using their smartphones, processing over 150,000 monthly transactions. The platform combines payment and loyalty features, providing retailers with a marketing tool for in-store customer engagement and targeted rewards based on purchase history. Yoyo Wallet serves retailers, universities, and corporate locations across the United Kingdom.

Garrison

Series B in 2018
Garrison Technology Limited, established in 2014 and located in London, specializes in cybersecurity solutions tailored for enterprise needs. The company has developed an innovative anti-malware product designed to protect organizations from significant cyber threats, particularly internet-borne targeted attacks. Garrison's technology addresses critical security challenges faced by enterprises and cloud computing, effectively mitigating risks associated with malware, phishing, and other web-borne threats. This solution allows users to securely access web content, ensuring safe browsing and secure data transfer while maintaining a high-quality user experience. Garrison aims to meet the increasing demands of the enterprise cybersecurity market by providing ultra-secure internet connectivity and scalable solutions.

Dukosi

Venture Round in 2018
Dukosi Ltd specializes in the design, development, and manufacturing of battery management systems, primarily targeting the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, the company offers advanced cell sensor products for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility vehicles. Dukosi's innovative solutions enable real-time monitoring of individual battery cell performance, enhancing the health and longevity of battery systems. Their products also contribute to the efficiency of smart grids, providing reliable and renewable energy solutions for various applications, including transport networks and residential use.

Artios Pharma

Series B in 2018
Artios Pharma Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in developing innovative cancer treatments targeting DNA damage response (DDR) pathways. Founded in 2015, the company is dedicated to creating first-in-class therapies aimed at selectively killing cancer cells. Artios's product pipeline features several promising programs, including a focus on DNA polymerase theta (Polθ), which plays a crucial role in DNA repair processes. Additionally, the company is advancing an in-licensed program that targets a newly identified protein linked to DDR and is developing a novel treatment aimed at DNA nucleases involved in these pathways. Artios collaborates with Cancer Research Technology and prominent DNA repair researchers globally to enhance its research and development efforts.

Spirea

Pre Seed Round in 2018
Spirea Ltd. is a healthcare technology company based in Harrogate, United Kingdom, that specializes in developing antibody drug conjugates (ADCs) for cancer treatment. Founded in 2015, Spirea has created a smart polymer platform designed for the controlled delivery of drug combinations, thereby maximizing the clinical efficacy of therapies. The company's innovative approach to ADCs allows for a greater amount of drug payload to be specifically targeted to tumor cells, resulting in enhanced therapeutic effects while significantly minimizing side effects. This development enables healthcare providers to offer well-tolerated treatment options for a variety of cancers, ultimately aiming to improve the quality of life for patients.

Enterprise Therapeutics

Series B in 2018
Enterprise Therapeutics, established in 2014 and headquartered in Brighton, UK, is a drug discovery company focused on developing therapies for respiratory diseases. Its primary focus is on chronic obstructive pulmonary diseases, cystic fibrosis, and asthma. The company aims to create novel treatments that target the underlying mechanisms of mucus congestion, reducing lung infections and enhancing patients' quality of life.

Econic Technologies

Venture Round in 2018
Econic Technologies Ltd. is a UK-based chemical technology company that specializes in developing innovative processes for producing polymers and polyurethanes using carbon dioxide and epoxides. Founded in 2011 and located in Macclesfield, the company focuses on transforming waste CO2 into valuable materials through advanced catalyst chemistry. Its product offerings include polycarbonates and polycarbonate polyols, which find applications in various sectors such as mattresses, home insulation, footwear, packaging, and construction. The company’s technology not only reduces dependence on fossil fuels but also aims to provide environmental benefits by mitigating greenhouse gas emissions. With a team of skilled scientists and engineers operating from a state-of-the-art facility at Alderley Park, Econic Technologies is committed to advancing sustainable practices in the plastics industry while fostering economic growth.

Spirea

Pre Seed Round in 2017
Spirea Ltd. is a healthcare technology company based in Harrogate, United Kingdom, that specializes in developing antibody drug conjugates (ADCs) for cancer treatment. Founded in 2015, Spirea has created a smart polymer platform designed for the controlled delivery of drug combinations, thereby maximizing the clinical efficacy of therapies. The company's innovative approach to ADCs allows for a greater amount of drug payload to be specifically targeted to tumor cells, resulting in enhanced therapeutic effects while significantly minimizing side effects. This development enables healthcare providers to offer well-tolerated treatment options for a variety of cancers, ultimately aiming to improve the quality of life for patients.

Oxehealth

Venture Round in 2017
Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring solutions. Founded in 2012, the company has developed the Oxecam software, which enables the measurement of heart rate, respiratory rate, and blood oxygenation using a digital video camera. This innovative system is particularly beneficial in healthcare settings, including mental health facilities and care homes, where staff may not always be present to monitor patients. Oxehealth's technology provides alerts for potentially risky activities and offers objective data for care planning, enhancing the ability of clinicians and caregivers to support vulnerable individuals. By employing advanced algorithms that utilize deep learning and computer vision, Oxehealth aims to improve patient monitoring and management while allowing staff more time for direct care. The company has achieved world-first certification for its software as a medical device, marking a significant advancement in remote patient monitoring.

Navenio

Seed Round in 2017
Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.

Kudo

Venture Round in 2017
Kudo Insurance is a mobile application that evaluates drivers' behavior through telematics, allowing users to receive personalized car insurance quotes based on their driving performance. By taking a driving assessment, users can earn Kudo Koins, which can be redeemed for various goods or entries into cash prize draws. This gamified approach enhances user engagement and encourages referrals, contributing to sustained app usage. Additionally, the app captures driving data that can serve as evidence in case of accidents. Kudo Insurance aims to leverage innovative data science and customer self-service techniques to establish itself as a leading motor insurer, initially targeting the UK market with plans for international expansion in the next few years.

Touchstone Innovations

Acquisition in 2017
Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.

Inductosense

Series A in 2017
Inductosense Ltd specializes in the manufacture of wireless, battery-free sensors that detect cracks, corrosion, and defects in various structures and products. Founded in 2015 and based in Bristol, United Kingdom, the company has developed the Wireless And Non Destructive (WAND) Evaluation System, which includes a handheld measurement probe and a set of sensors that can be permanently attached to surfaces. These sensors operate under coatings, insulation, or repairs, allowing for efficient and non-invasive inspections. Additionally, Inductosense offers TRND systems designed for monitoring internal corrosion and erosion in pipework and vessels. Their technology facilitates fast, repeatable inspections and enables clients to gather consistent data on structural integrity over time, making it valuable for applications in large structures and composite repairs.

Eight19

Venture Round in 2017
Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacturing of organic photovoltaics (OPVs) for lightweight solar panels. Founded in 2010, the company focuses on energy harvesting solutions for indoor, outdoor, and off-grid applications. Its OPV modules are designed for use in wireless devices, retail environments, and portable electronics, benefiting from attributes such as flexibility, thinness, and robustness. Eight19 employs industry-standard roll-to-roll processes and solution-based organic materials, allowing for a cost-effective scaling of its technology to meet market demands. The company also offers integrated demonstration units that include Bluetooth-connected temperature and light sensors, showcasing the versatility of its products in various applications.

Creavo Medical Technologies

Series B in 2017
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative diagnostic technologies for acute medical settings. Founded in 2014, the company aims to enhance patient care by providing a portable, battery-powered device that enables the detection of heart-related issues, specifically acute coronary syndromes and ischemia. This technology allows for magnetocardiography to be performed directly at the patient's bedside, facilitating timely diagnosis and treatment. Creavo Medical Technologies, which has facilities in Leeds and Coventry, was established by a group of experts in clinical research and business to commercialize advancements developed by Professor Ben Varcoe from Leeds University.

Alesi Surgical

Venture Round in 2017
Alesi Surgical Ltd. specializes in the development and commercialization of laparoscopic surgical smoke handling systems aimed at enhancing the safety and outcomes of surgical procedures. Founded in 2009 and based in Cardiff, United Kingdom, the company emerged as a spin-out from the Welsh Institute for Minimal Access Therapy, benefiting from direct access to experienced surgeons and surgical trainers. Alesi Surgical's innovative products are designed to be portable and applicable in both laparoscopic and robot-assisted surgeries. Utilizing electrostatic precipitation technology, these tools effectively eliminate surgical smoke, ensuring a clear visual field during procedures. Alesi Surgical distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia.

Ultraleap

Series B in 2017
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Saw DX

Venture Round in 2017
SAW DX Ltd is a technology development company based in Glasgow, United Kingdom, that specializes in designing and manufacturing point-of-care (POC) diagnostic devices. Founded in 2013, the company focuses on leveraging Acoustic-Flow technology, which utilizes surface acoustic waves to facilitate diagnostic tests. This innovative approach allows for the manipulation of patient samples on disposable chips, enabling fluid movement, mixing, and the release of DNA without the need for preprocessing. SAW DX's product portfolio includes prototypes for diagnosing sexually transmitted infections, a reader and cartridge system for tuberculosis assays, and a platform for parasite enrichment and molecular detection. By providing advanced diagnostic solutions, SAW DX aims to support life sciences and diagnostics companies in improving their product offerings and enhancing the efficiency of infectious disease diagnosis.

Dukosi

Series A in 2017
Dukosi Ltd specializes in the design, development, and manufacturing of battery management systems, primarily targeting the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, the company offers advanced cell sensor products for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility vehicles. Dukosi's innovative solutions enable real-time monitoring of individual battery cell performance, enhancing the health and longevity of battery systems. Their products also contribute to the efficiency of smart grids, providing reliable and renewable energy solutions for various applications, including transport networks and residential use.

Parkwalk Advisors

Acquisition in 2016
Parkwalk Advisors, established in 2009 and headquartered in London, is a venture capital firm specializing in investing in UK-based technology companies spun out from universities. The firm focuses on sectors such as AI, big data, life science, materials, cleantech, medtech, and quantum computing, typically investing between £2.5 million and £10 million. Parkwalk seeks to generate capital gains for its investors, enhanced by attractive tax reliefs like the Enterprise Investment Scheme (EIS). It operates as a subsidiary of IP Group Plc since 2017, with combined net assets of £1.2 billion as of March 2019.

Oxford Nanopore Technologies

Venture Round in 2016
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

AccelerComm

Seed Round in 2016
AccelerComm Ltd specializes in providing Forward Error Correction (FEC) solutions for various communication markets, including mobile handsets, base stations, and satellite standards. Founded in 2016 and based in Southampton, United Kingdom, the company focuses on enhancing the performance of next-generation wireless communications, addressing challenges such as noise, interference, and weak signal strength. Its product offerings include a range of encoding and decoding technologies, such as Polar, Turbo, and LDPC (Low-Density Parity-Check) decoders, specifically designed to meet 3GPP compliance. By delivering innovative semiconductor IP-core products, AccelerComm aims to facilitate optimal performance in digital communications while supporting the evolving needs of the industry.

Cambridge Innovation Capital

Venture Round in 2016
Cambridge Innovation Capital, established in 2013, is a venture capital firm based in Cambridge, UK. It specializes in early-stage investments, focusing on life sciences and technology companies with affiliations to the University of Cambridge or the Cambridge Cluster. The firm invests in a wide range of sectors, including healthcare, therapeutics, medtech, digital health, genomics, and emerging technologies such as AI, IoT, and quantum technologies. Cambridge Innovation Capital typically invests up to £19 million per company, providing long-term equity finance to support the growth and commercial development of innovative businesses. As a preferred investor for the University of Cambridge, the firm has access to a robust pipeline of investment opportunities within the ecosystem. Since its inception, Cambridge Innovation Capital has raised £275 million to fund disruptive, deep-tech businesses.

Mixergy

Seed Round in 2016
Mixergy Ltd, founded in 2014 and based in Cassington, United Kingdom, specializes in the development of energy storage equipment, particularly hot water tanks. The company aims to provide cost-effective solutions that enhance energy efficiency and support the integration of renewable energy sources. By optimizing the use of solar photovoltaic systems and heat pumps, Mixergy tanks contribute to grid balancing, promoting greater utilization of renewable power generation.

Navenio

Seed Round in 2016
Navenio Limited is a software technology company based in Oxford, United Kingdom, that specializes in location-based services for indoor environments. Founded in 2015, Navenio offers a mobile application solution that enhances indoor localization by enabling the tracking of individuals without the need for additional hardware, such as beacons or Wi-Fi. This innovative approach utilizes fingerprinting of the electromagnetic spectrum, sensor data, and indoor mapping to provide accurate location monitoring across various sectors, including retail, transportation, venues, and healthcare. Navenio's intelligent workforce solution significantly improves operational efficiency and workflow by automating processes based on real-world best practices.

Ultraleap

Series A in 2015
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

BOXARR

Seed Round in 2015
BOXARR Limited is a software company based in Bristol, United Kingdom, that specializes in systems engineering, supply chain management, and product development solutions for both public and commercial sectors. The company offers a comprehensive platform that facilitates effective management of complex interdependencies within organizational systems. Its suite of products includes tools for collaborative modeling, supply chain design, risk management, profitability optimization, and detailed value stream mapping. Additionally, BOXARR provides consultancy, implementation, and technical services, focusing on issue resolution and support. Its solutions are particularly utilized by manufacturers in the aerospace and defense industries to enhance visibility and efficiency across supply chains. Established in 2003 and formerly known as Plexus Planning Limited, BOXARR rebranded in May 2015 and operates internationally through a network of Alliance Partners.

Dukosi

Venture Round in 2015
Dukosi Ltd specializes in the design, development, and manufacturing of battery management systems, primarily targeting the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, the company offers advanced cell sensor products for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility vehicles. Dukosi's innovative solutions enable real-time monitoring of individual battery cell performance, enhancing the health and longevity of battery systems. Their products also contribute to the efficiency of smart grids, providing reliable and renewable energy solutions for various applications, including transport networks and residential use.

Seren Photonics

Venture Round in 2015
Seren Photonics Limited specializes in the development and manufacturing of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for various applications including light emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. The company has established a manufacturing process that significantly enhances light intensity in high-brightness LEDs, achieving light generation increases between 100% to 900% compared to standard diodes, all while maintaining low production costs. Seren Photonics grows semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire, catering to various markets such as backlighting for laptops and televisions, signage, displays, and architectural lighting. Founded in 2009 and located in Bridgend, United Kingdom, Seren Photonics Limited operates as a subsidiary of Fusion IP Sheffield Limited.

First Light Fusion

Venture Round in 2015
First Light Fusion Limited, founded in 2011 and based in Begbroke, United Kingdom, specializes in advanced implosion processes for electricity generation through inertial confinement fusion. The company originated as a spin-out from the University of Oxford and actively engages in researching and developing sustainable renewable energy solutions. It employs a team of engineers and physicists and collaborates with several academic institutions, including the University of Oxford, Warwick University, UCL, and Imperial College London. First Light Fusion focuses on harnessing fundamental physics to discover new energy sources, utilizing detailed numerical simulations and experimental validation in its research efforts.

Oxford Nanopore Technologies

Venture Round in 2015
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Anacail

Series A in 2015
Anacail Limited is a technology company based in Glasgow, United Kingdom, that specializes in the generation of ozone within sealed packages to effectively eliminate surface contaminants and microorganisms. The company's innovative in-pack ozone system includes an ozone head that produces intense electric fields to create plasma and generate ozone after the packaging has been sealed. This technology not only enhances food safety by providing rapid and chemical-free sterilization but also eliminates the handling and safety concerns typically associated with ozone use. Anacail develops equipment for food processing lines to generate sterilizing ozone and devices aimed at medical sterilization, ensuring a decontaminated package and contents without residual chemicals. Established in 2010, Anacail is focused on delivering safe and efficient sterilization solutions.

Relitect

Seed Round in 2015
Relitect Limited is a biotechnology company based in Motherwell, United Kingdom, founded in 2014. The company focuses on developing a novel assay platform for the label-free electrochemical detection of binding events. This proprietary technology enables the analysis of proteins, small molecules, and nucleic acids, making it applicable in clinical diagnostics and life sciences. Relitect's approach allows for the detection of highly sensitive biomarkers and other analytes in a multiplexed format, which utilizes small sample volumes and minimizes sample interference. By eliminating the potential for labeled reagent cross-talk, Relitect’s technology offers significant advantages for diagnostic and research applications, enhancing the capabilities of clinical diagnostics and life science companies.

Dukosi

Venture Round in 2014
Dukosi Ltd specializes in the design, development, and manufacturing of battery management systems, primarily targeting the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, the company offers advanced cell sensor products for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility vehicles. Dukosi's innovative solutions enable real-time monitoring of individual battery cell performance, enhancing the health and longevity of battery systems. Their products also contribute to the efficiency of smart grids, providing reliable and renewable energy solutions for various applications, including transport networks and residential use.

Eight19

Venture Round in 2014
Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacturing of organic photovoltaics (OPVs) for lightweight solar panels. Founded in 2010, the company focuses on energy harvesting solutions for indoor, outdoor, and off-grid applications. Its OPV modules are designed for use in wireless devices, retail environments, and portable electronics, benefiting from attributes such as flexibility, thinness, and robustness. Eight19 employs industry-standard roll-to-roll processes and solution-based organic materials, allowing for a cost-effective scaling of its technology to meet market demands. The company also offers integrated demonstration units that include Bluetooth-connected temperature and light sensors, showcasing the versatility of its products in various applications.

Ultraleap

Seed Round in 2014
Ultraleap Limited is a leading developer of mid-air haptic control systems and 3D hand tracking technology. Formerly known as Ultrahaptics, the company specializes in creating solutions that utilize ultrasound to generate tactile sensations, enabling users to feel three-dimensional shapes and textures without physical contact. Its flagship products include the Leap Motion Controller, which captures hand movements, and the VR Developer Mount, designed for enhancing virtual reality experiences on various headsets. The company's innovative technology is applicable across multiple industries such as extended reality, automotive, digital signage, industrial automation, consumer electronics, and location-based entertainment. Established in 2013 and headquartered in Bristol, United Kingdom, Ultraleap also has a subsidiary in Silicon Valley, United States.

Intelligent Ultrasound Group

Venture Round in 2014
Intelligent Ultrasound Group is a company specializing in the development, marketing, and distribution of medical training simulators and clinical ultrasound software. Based in Cardiff, United Kingdom, it offers a range of innovative products designed to enhance the quality and reliability of medical ultrasound. Its clinical AI software products, including ScanNav Audit, ScanNav AutoCapture, and ScanNav AnatomyGuide, provide real-time support and automation in ultrasound procedures, such as fetal anomaly scans and the identification of key anatomical structures. The company's training simulators, such as ScanTrainer for obstetrics and gynecology, HeartWorks for cardiac training, and BodyWorks for emergency medicine, are widely used to educate medical professionals. Intelligent Ultrasound Group, which was founded in 2004 and formerly known as MedaPhor Group, has a significant presence in the United Kingdom, North America, and other international markets.

Perpetuum

Series C in 2014
Perpetuum Ltd. specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 and based in Southampton, United Kingdom, the company focuses on creating battery-free vibration energy harvesters and wireless sensor nodes for various applications, including rail, oil and gas, chemicals, power generation, and water treatment. Perpetuum's technology converts mechanical vibrations into electrical energy, enabling autonomous, maintenance-free wireless sensors that monitor equipment conditions and processes. This innovative approach enhances efficiency and safety in fleet management and services, particularly within the rail industry. As a technology spin-off from the University of Southampton, Perpetuum has established itself as a leader in vibration energy harvesting, providing practical solutions for wireless automation.

Blooie

Seed Round in 2014
Blooie Limited operates an intelligent conversation platform designed to enhance real-time engagement between businesses and their online customers. Founded in 2011 and based in Newcastle upon Tyne, United Kingdom, Blooie enables websites to facilitate conversations among users who share an interest in the content they encounter. The platform provides business owners with tools to engage in informed discussions, track conversions through detailed analytics, and maintain user interaction on their sites. By allowing users to chat with both business representatives and other customers, as well as connect with friends on social media, Blooie aims to improve customer satisfaction and drive conversions for online businesses.

Oxford Nanopore Technologies

Venture Round in 2014
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Diurnal

Venture Round in 2014
Diurnal Group plc is a specialty pharmaceutical company based in Cardiff, United Kingdom, that focuses on developing hormone therapeutics for chronic endocrine conditions. Founded in 2004, the company offers innovative treatments such as Alkindi, a replacement therapy for pediatric adrenal insufficiency in Europe. Diurnal is also advancing its product pipeline with Chronocort, which has completed Phase III clinical trials for congenital adrenal hyperplasia and adrenal insufficiency. Additionally, the company's early-stage pipeline includes Native Oral Testosterone for hypogonadism, a short interfering RNA therapy for adrenocorticotropin-dependent Cushing's syndrome, and a modified-release preparation of T3 hormone for hypothyroidism. Diurnal's research is centered on circadian-based endocrinology, aimed at providing effective and long-term solutions for patients with rare and chronic endocrine disorders.

Givey

Seed Round in 2014
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Seren Photonics

Venture Round in 2014
Seren Photonics Limited specializes in the development and manufacturing of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for various applications including light emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. The company has established a manufacturing process that significantly enhances light intensity in high-brightness LEDs, achieving light generation increases between 100% to 900% compared to standard diodes, all while maintaining low production costs. Seren Photonics grows semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire, catering to various markets such as backlighting for laptops and televisions, signage, displays, and architectural lighting. Founded in 2009 and located in Bridgend, United Kingdom, Seren Photonics Limited operates as a subsidiary of Fusion IP Sheffield Limited.

Oxehealth

Venture Round in 2014
Oxehealth Ltd. is a technology company based in Oxford, United Kingdom, that specializes in non-contact vital signs monitoring solutions. Founded in 2012, the company has developed the Oxecam software, which enables the measurement of heart rate, respiratory rate, and blood oxygenation using a digital video camera. This innovative system is particularly beneficial in healthcare settings, including mental health facilities and care homes, where staff may not always be present to monitor patients. Oxehealth's technology provides alerts for potentially risky activities and offers objective data for care planning, enhancing the ability of clinicians and caregivers to support vulnerable individuals. By employing advanced algorithms that utilize deep learning and computer vision, Oxehealth aims to improve patient monitoring and management while allowing staff more time for direct care. The company has achieved world-first certification for its software as a medical device, marking a significant advancement in remote patient monitoring.

Creavo Medical Technologies

Seed Round in 2014
Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative diagnostic technologies for acute medical settings. Founded in 2014, the company aims to enhance patient care by providing a portable, battery-powered device that enables the detection of heart-related issues, specifically acute coronary syndromes and ischemia. This technology allows for magnetocardiography to be performed directly at the patient's bedside, facilitating timely diagnosis and treatment. Creavo Medical Technologies, which has facilities in Leeds and Coventry, was established by a group of experts in clinical research and business to commercialize advancements developed by Professor Ben Varcoe from Leeds University.

Fusion IP

Acquisition in 2014
FusionIP is a company focused on commercializing university-owned research from two prominent UK institutions, The University of Sheffield and Cardiff University. By forming exclusive partnerships with these universities, FusionIP has the rights to develop innovative technologies in various fields, including clean energy, electronics, engineering, and medicine. The company transforms this world-class research into viable businesses by creating a diverse portfolio of companies. Additionally, FusionIP has previously engaged in funding universities to support the development of intellectual property, securing a share of the earnings generated from these rights. Through these initiatives, FusionIP aims to bridge the gap between academic research and market-ready solutions.

Blooie

Seed Round in 2013
Blooie Limited operates an intelligent conversation platform designed to enhance real-time engagement between businesses and their online customers. Founded in 2011 and based in Newcastle upon Tyne, United Kingdom, Blooie enables websites to facilitate conversations among users who share an interest in the content they encounter. The platform provides business owners with tools to engage in informed discussions, track conversions through detailed analytics, and maintain user interaction on their sites. By allowing users to chat with both business representatives and other customers, as well as connect with friends on social media, Blooie aims to improve customer satisfaction and drive conversions for online businesses.

Actual Experience

Funding Round in 2013
Actual Experience plc is an analytics-as-a-service company based in Bath, United Kingdom, specializing in human experience management and consultancy services. The company offers a cloud analytics platform that analyzes data from digital users to generate objective quality scores for digital experiences and supply chain performance. Its main products include the Analytics Cloud, which processes user data through algorithms, and the Dashboard, which provides actionable insights for service providers to identify issues affecting digital quality. Actual Experience also segments its services into Actual Work, Actual Home, and Actual Work Web, focusing on different aspects of digital service delivery. By leveraging science-backed analytics and data-driven insights, Actual Experience aims to enhance organizational effectiveness and improve both employee and customer experiences in the digital ecosystem. The company operates primarily in the United Kingdom and the United States.

Exonate

Seed Round in 2013
Exonate Limited is a private biotech company based in Duxford, United Kingdom, specializing in the discovery and development of small molecule drugs aimed at modulating alternative messenger RNA splicing for ophthalmological applications. Founded in 2013, the company emerged from the University of Nottingham and is focused on addressing retinal vascular diseases, particularly diabetic macular oedema (DMO) and wet age-related macular degeneration (wAMD). Exonate's lead program utilizes small molecule inhibitors that selectively target serine/threonine-protein kinase 1 to inhibit the production of pro-angiogenic vascular endothelial growth factor (VEGF) splice variants. This innovative approach aims to improve therapeutic outcomes and offers a potential alternative to current treatment methods, such as anti-VEGF injections and laser surgery. With a preclinical candidate drug already nominated, Exonate is advancing its research through regulatory toxicology and safety pharmacology studies to facilitate clinical evaluation. The company is backed by an experienced management team with expertise in medicine and drug development.

Verticly

Seed Round in 2013
Verticly, established in 2014 and headquartered in London, offers a SaaS platform that bridges online and offline customer data for FMCG brands, retailers, and manufacturers. It specializes in real-time, personalized engagement, providing solutions for omni-channel landscape, channel attribution, vouchering, and more. The company's platform facilitates data exchange and delivers targeted content to consumers, driving purchases and simplifying marketing for SMEs.

Oxford Nanopore Technologies

Venture Round in 2013
Oxford Nanopore Technologies is a biotechnology company specializing in nanopore-based sequencing technology for analyzing DNA, RNA, proteins, and small molecules. Its diverse product line includes the portable MinION device, the benchtop PromethION, the GridION system, and Flongle, which caters to on-demand sequencing needs. The technology enables real-time data streaming and is applicable across various fields such as human genomics, cancer research, microbiology, plant science, and environmental studies. Additionally, Oxford Nanopore's products support rapid and accessible molecular analysis, making them suitable for both laboratory and field use. The company's innovations are backed by a robust patent portfolio and are utilized in over 80 countries, addressing needs in healthcare, agriculture, and education. Founded in 2005 and headquartered in Oxford, United Kingdom, Oxford Nanopore also maintains offices in several other countries, enhancing its global reach in advancing genomic research and applications.

Ubiquigent

Seed Round in 2013
Ubiquigent Limited is a biotechnology company based in Dundee, United Kingdom, founded in 2009. It specializes in the development and supply of high-quality reagents, kits, and drug discovery assay development services, primarily targeting the life science research community. Ubiquigent focuses on protein degradation and the ubiquitin signaling systems, providing services that support drug discovery efforts aimed at developing novel deubiquitylase (DUB) enzyme inhibitors. The company works closely with academic researchers and pharmaceutical scientists, aiding in the exploration of therapeutic applications for DUB modulators in areas with significant unmet medical needs. Ubiquigent is committed to generating intellectual property through its innovative drug discovery programs, which include optimizing compounds that target the ubiquitin cascade.

Blooie

Seed Round in 2013
Blooie Limited operates an intelligent conversation platform designed to enhance real-time engagement between businesses and their online customers. Founded in 2011 and based in Newcastle upon Tyne, United Kingdom, Blooie enables websites to facilitate conversations among users who share an interest in the content they encounter. The platform provides business owners with tools to engage in informed discussions, track conversions through detailed analytics, and maintain user interaction on their sites. By allowing users to chat with both business representatives and other customers, as well as connect with friends on social media, Blooie aims to improve customer satisfaction and drive conversions for online businesses.

Xeros

Venture Round in 2013
Xeros Ltd. is a new company focused on the development of "virtually waterless" laundry cleaning. Harnessing over 30 years of research by Professor Stephen Burkinshaw and the University of Leeds, Xeros is the brand name for a patented polymer based cleaning that creates step change advantage in the cost and environmental impact of aqueous wash cleaning.

Givey

Seed Round in 2012
Givey Limited operates givey.com, a fee-free online community funding platform dedicated to raising donations for small charities and local communities in the UK. The platform enables users to create fundraising pages that can feature photos, videos, and links from various social media networks, facilitating easy sharing and engagement. It empowers businesses to support their employees' charitable efforts and allows charities to manage their fundraising activities effectively, including overseeing donations and communicating with supporters. With over 7,000 registered charities and a growing user base of more than 100,000 individuals, Givey enhances the digital presence of small charities and local non-profit groups, promoting social good and fostering community resilience. Founded in 1994 and based in London, Givey is committed to making charitable giving more accessible and impactful.

Magnomatics

Venture Round in 2012
Magnomatics Limited is a technology engineering company based in Sheffield, United Kingdom, founded in 2006 as a spin-out from the University of Sheffield. The company specializes in the development and manufacturing of products utilizing its proprietary magnetic gear technology, which includes high-torque low-speed motors and generators such as the Pseudo Direct Drive, as well as MAGSPLIT, a power-split continuously variable transmission solution. These innovations are aimed at various sectors, including oil and gas, automotive, aerospace, marine propulsion, renewable energy, and rail traction. Magnomatics' magnetic transmission systems offer an alternative to traditional mechanical gears, helping to reduce operating costs and lower carbon emissions in the hybrid and electric vehicle markets.

Adludio

Seed Round in 2012
Adludio, established in 2012 and headquartered in London, specializes in interactive mobile advertising. The company creates, delivers, and optimizes advertising campaigns at scale, using AI-powered technology, data, and algorithms to design and optimize ad creatives. Adludio partners with international publishers and brands, including global giants like Nike, Microsoft, and Chanel, as well as direct-to-consumer challengers. With offices across North America, Europe, and Asia, and a remote workforce spanning 17 countries, Adludio fosters a start-up culture and has been recognized for its growth and innovation, such as winning 'Best Mobile Campaign' at The Drum APAC Awards in 2018 and being listed in The Sunday Times Tech Track 100 'Ones to Watch'.

Fantoo

Seed Round in 2012
Fantoo Ltd., established in 2012 and based in Bracknell, UK, specializes in developing an online platform that enhances productivity by prioritizing and organizing emails and messages. Leveraging data analysis and artificial intelligence, the platform connects users with relevant people, files, and information feeds, consolidating tasks into a single, actionable list. It empowers users to emphasize important messages and turn them into actions, providing a comprehensive, distraction-free workspace for managing daily tasks and appointments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.